Participation of clinical pharmacists without specialized infectious diseases training in antimicrobial stewardship

DiazGranados, Carlos A.; Abd, Thura T.
September 2011
American Journal of Health-System Pharmacy;9/15/2011, Vol. 68 Issue 18, p1691
Academic Journal
A letter is presented in which the author discusses the participation of clinical pharmacists without specialized infectious diseases training in antimicrobial stewardship.


Related Articles

  • Pharmacists and Antimicrobial Stewardship. Duguid, Margaret // Journal of Pharmacy Practice & Research;Jun2011, Vol. 41 Issue 2, p92 

    The author reflects on the role that pharmacists can play in antimicrobial stewardship programs in hospitals. He suggests that a major cause of the development of antimicrobial resistance in hospitals is the unnecessary and inappropriate use of antimicrobials. He argues that pharmacists can play...

  • Failing to tackle drug-resistant superbugs will cost up to $100 trillion.  // Healthcare Purchasing News;Jan2015, Vol. 39 Issue 1, p18 

    The article discusses the Review on Antimicrobial Resistance study conducted by economist Jim O'Neill for British Prime Minister David Cameron to assess the global mortality and morbidity impact of superbug infection.

  • How to educate prescribers in antimicrobial stewardship practices. Pulcini, C�line; Gyssens, Inge C. // Virulence;2/15/2013, Vol. 4 Issue 2, p192 

    Widespread antimicrobial use has compromised its value, leading to a crisis of antimicrobial resistance. A major cause of misuse is insufcient knowledge of prescribing of antimicrobials in many categories of professionals. An important principle of antimicrobial stewardship is avoiding selection...

  • The Use and Interpretation of Quasi-Experimental Studies in Infectious Diseases. Harris, Anthony D.; Bradham, Douglas D.; Baumgarten, Mona; Zuckerman, Ilene H.; Fink, Jeffrey C.; Perencevich, Eli N. // Clinical Infectious Diseases;6/1/2004, Vol. 38 Issue 11, p1586 

    Quasi-experimental study designs, sometimes called nonrandomized, pre-post-intervention study designs, are ubiquitous in the infectious diseases literature, particularly in the area of interventions aimed at decreasing the spread of antibiotic-resistant bacteria. Little has been written about...

  • XDR TB: How scary is it? Spak, Cedric W. // Cortlandt Forum;Jul2007, Vol. 20 Issue 7, p30 

    The article offers information about the drug-resistant tuberculosis (XDRTB). It is noted that XDR TB is killed by neither fluoroquinolones nor one of the more effective injectable antibiotics. The evolution of XDR TB is part of the natural history of resistance as MDR TB increases its ability...

  • Management of Persistent Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus: A Survey of Infectious Diseases Consultants. Hageman, Jeffrey C.; Liedtke, Laura A.; Sunenshine, Rebecca H.; Strausbaugh, Larry J.; McDonald, L. Clifford; Tenover, Fred C. // Clinical Infectious Diseases;9/1/2006, Vol. 43 Issue 5, pe42 

    We conducted a survey in 2005 of infectious diseases consultants and asked about persistent bacteremia due to methicillin-resistant Staphylococcus aureus. Many consultants perceived an increase in the frequency of illness, and, when presented with vancomycin minimum inhibitory concentrations...

  • Photodynamic medicine and infection control. Wainwright, Mark // Journal of Antimicrobial Chemotherapy (JAC);Apr2012, Vol. 67 Issue 4, p787 

    Given the problem of increasing antimicrobial—especially antibacterial—drug resistance and the paucity of new agents, it is sensible to consider alternative approaches to infection control to aid in conservation. Photoantimicrobials are highly active agents, regardless of the...

  • Minimizing Antimicrobial Resistance: The Key Role of the Infectious Diseases Physician. McGowan, Jr., John E. // Clinical Infectious Diseases;4/1/2004, Vol. 38 Issue 7, p939 

    Reports on the role of the infectious diseases physician (IDP) in minimizing antimicrobial resistance. Threat of antimicrobial resistance in bacteria; Consequences of bacterial drug resistance including increased mortality and morbidity; Role of IDP in implementation of strategies for...

  • Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management. Fuller, J.; McGeer, A.; Low, D. // European Journal of Clinical Microbiology & Infectious Diseases;Dec2005, Vol. 24 Issue 12, p780 

    Community-acquired pneumonia is the most common infectious disease that causes death, with Streptococcus pneumoniae remaining the leading causative pathogen. The worldwide incidence of infections caused by pneumococci resistant to penicillin, macrolides, and other antimicrobial agents has...

  • Snapshot of Antimicrobial Stewardship in Australian Hospitals. Chen, Alex W. J.; Khumra, Sharmila; Eaton, Vaughn; Kong, David C. M. // Journal of Pharmacy Practice & Research;Mar2010, Vol. 40 Issue 1, p19 

    Background: The diminishing investment into the development of new antimicrobials is of significant global concern. This, coupled with the emergence of anti-infective drug resistance, highlights the need to both prolong and optimise the use of existing antimicrobials. Strategies or programs to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics